Woodcock Touts Baby Steps Toward Global Manufacturing Quality Dossier

 
• By Derrick Gingery
  
convergence
Cell and gene therapy manufacturing likely is too new for regulatory convergence, Janet Woodcock said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance